Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China. - Fu ZC; Cheng XG; Zhang GW; Shi RG; Zhang LJ; Sun HT; Huang JX (International journal of rheumatic diseases, 2024)